Click here to get full coverage on The Skills Shortage is Here to Stay: Here’s What Organizations Need to Do Next - UC Today

The Skills Shortage is Here to Stay: Here’s What Organizations Need to Do Next  UC Today

The Skills Shortage is Here to Stay: Here’s What Organizations Need to Do Next - UC Today

Click here to get full coverage on 7 Ways to Manage Obstructive Hypertrophic Cardiomyopathy Symptoms - Everyday Health

7 Ways to Manage Obstructive Hypertrophic Cardiomyopathy Symptoms  Everyday Health

7 Ways to Manage Obstructive Hypertrophic Cardiomyopathy Symptoms - Everyday Health

Click here to get full coverage on Edgewise Therapeutics Teases Phase 3 Sevasemten Readout, HCM Data Update at Guggenheim Conference - Yahoo Finance

Edgewise Therapeutics Teases Phase 3 Sevasemten Readout, HCM Data Update at Guggenheim Conference  Yahoo Finance

Edgewise Therapeutics Teases Phase 3 Sevasemten Readout, HCM Data Update at Guggenheim Conference - Yahoo Finance

Click here to get full coverage on Cytokinetics Presents Additional Data from MAPLE-HCM at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025 - Cytokinetics

Cytokinetics Presents Additional Data from MAPLE-HCM at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025  Cytokinetics

Cytokinetics Presents Additional Data from MAPLE-HCM at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025 - Cytokinetics

Click here to get full coverage on Ancient HCM City temple draws crowds for ‘beating the petty spirit’ ritual - Báo VietNamNet

Ancient HCM City temple draws crowds for ‘beating the petty spirit’ ritual  Báo VietNamNet

Ancient HCM City temple draws crowds for ‘beating the petty spirit’ ritual - Báo VietNamNet

Click here to get full coverage on 3 HCM Stocks to Consider After January's Strong U.S. Jobs Report - Nasdaq

3 HCM Stocks to Consider After January's Strong U.S. Jobs Report  Nasdaq

3 HCM Stocks to Consider After January's Strong U.S. Jobs Report - Nasdaq

Click here to get full coverage on Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy - The New England Journal of Medicine

Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy  The New England Journal of Medicine

Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy - The New England Journal of Medicine

Click here to get full coverage on Asymptomatic Hypertrophic Cardiomyopathy: Insights on Long-Term Outcomes and More - Cleveland Clinic

Asymptomatic Hypertrophic Cardiomyopathy: Insights on Long-Term Outcomes and More  Cleveland Clinic

Asymptomatic Hypertrophic Cardiomyopathy: Insights on Long-Term Outcomes and More - Cleveland Clinic

Click here to get full coverage on EWTX: Phase 3 Becker data, HCM updates, and commercial launch prep highlight a pivotal year - TradingView

EWTX: Phase 3 Becker data, HCM updates, and commercial launch prep highlight a pivotal year  TradingView

EWTX: Phase 3 Becker data, HCM updates, and commercial launch prep highlight a pivotal year - TradingView

Click here to get full coverage on Expanded effort will help standardize, improve care for hypertrophic cardiomyopathy - www.heart.org

Expanded effort will help standardize, improve care for hypertrophic cardiomyopathy  www.heart.org

Expanded effort will help standardize, improve care for hypertrophic cardiomyopathy - www.heart.org

Click here to get full coverage on The Clinical Challenge of Diagnosing Hypertrophic Cardiomyopathy at Midwest Medical Center - Clinical Advisor

The Clinical Challenge of Diagnosing Hypertrophic Cardiomyopathy at Midwest Medical Center  Clinical Advisor

The Clinical Challenge of Diagnosing Hypertrophic Cardiomyopathy at Midwest Medical Center - Clinical Advisor

Click here to get full coverage on MAPLE-HCM Is a Win, ODYSSEY-HCM Isn’t: Obstructive vs Nonobstructive Divide - TCTMD.com

MAPLE-HCM Is a Win, ODYSSEY-HCM Isn’t: Obstructive vs Nonobstructive Divide  TCTMD.com

MAPLE-HCM Is a Win, ODYSSEY-HCM Isn’t: Obstructive vs Nonobstructive Divide - TCTMD.com

Click here to get full coverage on Prioritize Emotional Health When You Have Obstructive Hypertrophic Cardiomyopathy - Everyday Health

Prioritize Emotional Health When You Have Obstructive Hypertrophic Cardiomyopathy  Everyday Health

Prioritize Emotional Health When You Have Obstructive Hypertrophic Cardiomyopathy - Everyday Health

Click here to get full coverage on Cytokinetics Announces FDA Approval of MYQORZO™ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms - Cytokinetics

Cytokinetics Announces FDA Approval of MYQORZO™ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms  Cytokinetics

Cytokinetics Announces FDA Approval of MYQORZO™ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms - Cytokinetics

Click here to get full coverage on Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy - The New England Journal of Medicine

Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy  The New England Journal of Medicine

Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy - The New England Journal of Medicine

Click here to get full coverage on Obstructive Hypertrophic Cardiomyopathy: Tips to Modify Daily Tasks - Everyday Health

Obstructive Hypertrophic Cardiomyopathy: Tips to Modify Daily Tasks  Everyday Health

Obstructive Hypertrophic Cardiomyopathy: Tips to Modify Daily Tasks - Everyday Health

Click here to get full coverage on Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine - Cytokinetics

Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine  Cytokinetics

Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine - Cytokinetics

Click here to get full coverage on Your Hypertrophic Cardiomyopathy (HCM) Symptoms: When to Call Your Doctor and When to Call 911 - Everyday Health

Your Hypertrophic Cardiomyopathy (HCM) Symptoms: When to Call Your Doctor and When to Call 911  Everyday Health

Your Hypertrophic Cardiomyopathy (HCM) Symptoms: When to Call Your Doctor and When to Call 911 - Everyday Health

Click here to get full coverage on Hypertrophic Cardiomyopathy (HCM) Surgery: Know Your Options - Everyday Health

Hypertrophic Cardiomyopathy (HCM) Surgery: Know Your Options  Everyday Health

Hypertrophic Cardiomyopathy (HCM) Surgery: Know Your Options - Everyday Health

Click here to get full coverage on Hypertrophic Cardiomyopathy (HCM) and Implantable Devices: What to Know About ICDs (and Other Options) - Everyday Health

Hypertrophic Cardiomyopathy (HCM) and Implantable Devices: What to Know About ICDs (and Other Options)  Everyday Health

Hypertrophic Cardiomyopathy (HCM) and Implantable Devices: What to Know About ICDs (and Other Options) - Everyday Health

Click here to get full coverage on Myosin Inhibitor for Nonobstructive HCM: No Clinical Benefits but Positive Biomarker and Echo Effects - Cleveland Clinic

Myosin Inhibitor for Nonobstructive HCM: No Clinical Benefits but Positive Biomarker and Echo Effects  Cleveland Clinic

Myosin Inhibitor for Nonobstructive HCM: No Clinical Benefits but Positive Biomarker and Echo Effects - Cleveland Clinic

Click here to get full coverage on What Causes Hypertrophic Cardiomyopathy? - Verywell Health

What Causes Hypertrophic Cardiomyopathy?  Verywell Health

What Causes Hypertrophic Cardiomyopathy? - Verywell Health

Click here to get full coverage on Cardiac myosin inhibitors for the treatment of obstructive and non-obstructive HCM - Nature

Cardiac myosin inhibitors for the treatment of obstructive and non-obstructive HCM  Nature

Cardiac myosin inhibitors for the treatment of obstructive and non-obstructive HCM - Nature

Click here to get full coverage on What’s New in PeopleSoft’s HCM Update Image 54: Key Enhancements and Features - Oracle Blogs

What’s New in PeopleSoft’s HCM Update Image 54: Key Enhancements and Features  Oracle Blogs

What’s New in PeopleSoft’s HCM Update Image 54: Key Enhancements and Features - Oracle Blogs

Click here to get full coverage on Imbria Pharmaceuticals, HCMS Team Up to Support Fortitude-HCM Trial - Diagnostic and Interventional Cardiology

Imbria Pharmaceuticals, HCMS Team Up to Support Fortitude-HCM Trial  Diagnostic and Interventional Cardiology

Imbria Pharmaceuticals, HCMS Team Up to Support Fortitude-HCM Trial - Diagnostic and Interventional Cardiology

Click here to get full coverage on Oracle Named a Leader in Gartner® Magic Quadrant™ for Cloud HCM Suites for 1,000+ Employee Enterprises for 10th Consecutive Year - Oracle

Oracle Named a Leader in Gartner® Magic Quadrant™ for Cloud HCM Suites for 1,000+ Employee Enterprises for 10th Consecutive Year  Oracle

Oracle Named a Leader in Gartner® Magic Quadrant™ for Cloud HCM Suites for 1,000+ Employee Enterprises for 10th Consecutive Year - Oracle

Click here to get full coverage on Left ventricular septal convexity in differentiating hypertrophic cardiomyopathy from hypertensive heart disease – a cardiac magnetic resonance study - Nature

Left ventricular septal convexity in differentiating hypertrophic cardiomyopathy from hypertensive heart disease – a cardiac magnetic resonance study  Nature

Left ventricular septal convexity in differentiating hypertrophic cardiomyopathy from hypertensive heart disease – a cardiac magnetic resonance study - Nature

Click here to get full coverage on Can You Exercise With Hypertrophic Cardiomyopathy? - Cleveland Clinic Health Essentials

Can You Exercise With Hypertrophic Cardiomyopathy?  Cleveland Clinic Health Essentials

Can You Exercise With Hypertrophic Cardiomyopathy? - Cleveland Clinic Health Essentials

Click here to get full coverage on Human Capital Management & the Benefits of HCM Software - Business.com

Human Capital Management & the Benefits of HCM Software  Business.com

Human Capital Management & the Benefits of HCM Software - Business.com

Click here to get full coverage on Redefining the Genetic Architecture of Hypertrophic Cardiomyopathy: Role of Intermediate-Effect Variants | Circulation - American Heart Association Journals

Redefining the Genetic Architecture of Hypertrophic Cardiomyopathy: Role of Intermediate-Effect Variants | Circulation  American Heart Association Journals

Redefining the Genetic Architecture of Hypertrophic Cardiomyopathy: Role of Intermediate-Effect Variants | Circulation - American Heart Association Journals

Click here to get full coverage on New Insights About the Effects of Valsartan on Early-Stage Hypertrophic Cardiomyopathy - Cleveland Clinic

New Insights About the Effects of Valsartan on Early-Stage Hypertrophic Cardiomyopathy  Cleveland Clinic

New Insights About the Effects of Valsartan on Early-Stage Hypertrophic Cardiomyopathy - Cleveland Clinic

Click here to get full coverage on Hypertrophic Cardiomyopathy Association supports study of potential treatment for nonbstructive HCM - Cardiovascular Business

Hypertrophic Cardiomyopathy Association supports study of potential treatment for nonbstructive HCM  Cardiovascular Business

Hypertrophic Cardiomyopathy Association supports study of potential treatment for nonbstructive HCM - Cardiovascular Business

Click here to get full coverage on Characterization and Application of Novel Exercise Recovery Patterns That Reflect Cardiac Performance: A Substudy of the SEQUOIA-HCM Trial | Circulation - American Heart Association Journals

Characterization and Application of Novel Exercise Recovery Patterns That Reflect Cardiac Performance: A Substudy of the SEQUOIA-HCM Trial | Circulation  American Heart Association Journals

Characterization and Application of Novel Exercise Recovery Patterns That Reflect Cardiac Performance: A Substudy of the SEQUOIA-HCM Trial | Circulation - American Heart Association Journals

Click here to get full coverage on Genetic determinants of the phenotype in a Swedish cohort of patients with hypertrophic cardiomyopathy - Nature

Genetic determinants of the phenotype in a Swedish cohort of patients with hypertrophic cardiomyopathy  Nature

Genetic determinants of the phenotype in a Swedish cohort of patients with hypertrophic cardiomyopathy - Nature

Click here to get full coverage on Aficamten versus Metoprolol in Obstructive Hypertrophic Cardiomyopathy: Recent Analyses of the MAPLE-HCM Trial - European Medical Journal

Aficamten versus Metoprolol in Obstructive Hypertrophic Cardiomyopathy: Recent Analyses of the MAPLE-HCM Trial  European Medical Journal

Aficamten versus Metoprolol in Obstructive Hypertrophic Cardiomyopathy: Recent Analyses of the MAPLE-HCM Trial - European Medical Journal

Click here to get full coverage on FDA Approves Aficamten for Obstructive HCM - TCTMD.com

FDA Approves Aficamten for Obstructive HCM  TCTMD.com

FDA Approves Aficamten for Obstructive HCM - TCTMD.com

Click here to get full coverage on Multimodal AI to forecast arrhythmic death in hypertrophic cardiomyopathy - Nature

Multimodal AI to forecast arrhythmic death in hypertrophic cardiomyopathy  Nature

Multimodal AI to forecast arrhythmic death in hypertrophic cardiomyopathy - Nature

Click here to get full coverage on 96-Week FOREST-HCM Data Support Aficamten Use in Nonobstructive HCM - HCPLive

96-Week FOREST-HCM Data Support Aficamten Use in Nonobstructive HCM  HCPLive

96-Week FOREST-HCM Data Support Aficamten Use in Nonobstructive HCM - HCPLive

Click here to get full coverage on Advances in feline hypertrophic cardiomyopathy (HCM): Diagnosis, management, and future directions - DVM360

Advances in feline hypertrophic cardiomyopathy (HCM): Diagnosis, management, and future directions  DVM360

Advances in feline hypertrophic cardiomyopathy (HCM): Diagnosis, management, and future directions - DVM360

Click here to get full coverage on PeopleSoft HCM to be unavailable early Sunday | CWRU Newsroom - Case Western Reserve University

PeopleSoft HCM to be unavailable early Sunday | CWRU Newsroom  Case Western Reserve University

PeopleSoft HCM to be unavailable early Sunday | CWRU Newsroom - Case Western Reserve University

Click here to get full coverage on Cardiopulmonary Exercise Testing for Characterization of Hypertrophic Cardiomyopathy: A Meta‐Analysis - American Heart Association Journals

Cardiopulmonary Exercise Testing for Characterization of Hypertrophic Cardiomyopathy: A Meta‐Analysis  American Heart Association Journals

Cardiopulmonary Exercise Testing for Characterization of Hypertrophic Cardiomyopathy: A Meta‐Analysis - American Heart Association Journals

Click here to get full coverage on Voices of HCM: Patient stories from across the globe - Bristol Myers Squibb

Voices of HCM: Patient stories from across the globe  Bristol Myers Squibb

Voices of HCM: Patient stories from across the globe - Bristol Myers Squibb

Click here to get full coverage on Aficamten Updates in Two Hypertrophic Cardiomyopathy Trials - Medscape

Aficamten Updates in Two Hypertrophic Cardiomyopathy Trials  Medscape

Aficamten Updates in Two Hypertrophic Cardiomyopathy Trials - Medscape

Click here to get full coverage on Cytokinetics, Olympic Medalist McLaughlin-Levrone team up for awareness for HCM - Yahoo Finance

Cytokinetics, Olympic Medalist McLaughlin-Levrone team up for awareness for HCM  Yahoo Finance

Cytokinetics, Olympic Medalist McLaughlin-Levrone team up for awareness for HCM - Yahoo Finance

Click here to get full coverage on Epistasis regulates genetic control of cardiac hypertrophy - Nature

Epistasis regulates genetic control of cardiac hypertrophy  Nature

Epistasis regulates genetic control of cardiac hypertrophy - Nature

Click here to get full coverage on How to Tell if Your HCM Treatment Is Working - HealthCentral

How to Tell if Your HCM Treatment Is Working  HealthCentral

How to Tell if Your HCM Treatment Is Working - HealthCentral

Click here to get full coverage on Managing the Most Common Inherited Disease of the Heart Muscle: Hypertrophic Cardiomyopathy - University of Utah Health

Managing the Most Common Inherited Disease of the Heart Muscle: Hypertrophic Cardiomyopathy  University of Utah Health

Managing the Most Common Inherited Disease of the Heart Muscle: Hypertrophic Cardiomyopathy - University of Utah Health

Click here to get full coverage on 9 Questions to Ask Your Doctor About HCM - HealthCentral

9 Questions to Ask Your Doctor About HCM  HealthCentral

9 Questions to Ask Your Doctor About HCM - HealthCentral

Click here to get full coverage on HCM City strengthens fintech and AI cooperation at WEF Davos 2026 - vietnamnews.vn

HCM City strengthens fintech and AI cooperation at WEF Davos 2026  vietnamnews.vn

HCM City strengthens fintech and AI cooperation at WEF Davos 2026 - vietnamnews.vn

Click here to get full coverage on Hypertrophic Cardiomyopathy - The New England Journal of Medicine

Hypertrophic Cardiomyopathy  The New England Journal of Medicine

Hypertrophic Cardiomyopathy - The New England Journal of Medicine

Click here to get full coverage on Woman’s shortness of breath was first sign of serious health condition HCM - The Medical University of South Carolina

Woman’s shortness of breath was first sign of serious health condition HCM  The Medical University of South Carolina

Woman’s shortness of breath was first sign of serious health condition HCM - The Medical University of South Carolina

Click here to get full coverage on ESC25: Cytokinetics says new aficamten data may upend HCM treatment norms - FirstWord Pharma

ESC25: Cytokinetics says new aficamten data may upend HCM treatment norms  FirstWord Pharma

ESC25: Cytokinetics says new aficamten data may upend HCM treatment norms - FirstWord Pharma

Click here to get full coverage on MAPLE-HCM: Aficamten Proves Superiority to Metoprolol in Hypertrophic Cardiomyopathy - HCPLive

MAPLE-HCM: Aficamten Proves Superiority to Metoprolol in Hypertrophic Cardiomyopathy  HCPLive

MAPLE-HCM: Aficamten Proves Superiority to Metoprolol in Hypertrophic Cardiomyopathy - HCPLive

Click here to get full coverage on Exercising With Hypertrophic Cardiomyopathy (HCM): What You Need to Know - Everyday Health

Exercising With Hypertrophic Cardiomyopathy (HCM): What You Need to Know  Everyday Health

Exercising With Hypertrophic Cardiomyopathy (HCM): What You Need to Know - Everyday Health

Click here to get full coverage on Genetics and Family Risk: What to Know if You Have Hypertrophic Cardiomyopathy (HCM) - Everyday Health

Genetics and Family Risk: What to Know if You Have Hypertrophic Cardiomyopathy (HCM)  Everyday Health

Genetics and Family Risk: What to Know if You Have Hypertrophic Cardiomyopathy (HCM) - Everyday Health

Click here to get full coverage on Hypertrophic cardiomyopathy - Nature

Hypertrophic cardiomyopathy - Nature

Click here to get full coverage on Achieving successful outcomes with mitral valve repair for degenerative mitral regurgitation in patients with obstructive HCM undergoing myectomy - Mayo Clinic

Achieving successful outcomes with mitral valve repair for degenerative mitral regurgitation in patients with obstructive HCM undergoing myectomy  Mayo Clinic

Achieving successful outcomes with mitral valve repair for degenerative mitral regurgitation in patients with obstructive HCM undergoing myectomy - Mayo Clinic

Click here to get full coverage on Targeted Therapy Nears EU Approval for Obstructive HCM - Medscape

Targeted Therapy Nears EU Approval for Obstructive HCM  Medscape

Targeted Therapy Nears EU Approval for Obstructive HCM - Medscape

Click here to get full coverage on SAP in Gartner Cloud HCM Suites Magic Quadrant - SAP News Center

SAP in Gartner Cloud HCM Suites Magic Quadrant  SAP News Center

SAP in Gartner Cloud HCM Suites Magic Quadrant - SAP News Center

Click here to get full coverage on Habits to Improve Your Health When Living with HCM - HealthCentral

Habits to Improve Your Health When Living with HCM  HealthCentral

Habits to Improve Your Health When Living with HCM - HealthCentral

Click here to get full coverage on HCM IV Acquisition Corp. Announces Closing of $287,500,000 Initial Public Offering - The Manila Times

HCM IV Acquisition Corp. Announces Closing of $287,500,000 Initial Public Offering  The Manila Times

HCM IV Acquisition Corp. Announces Closing of $287,500,000 Initial Public Offering - The Manila Times

Click here to get full coverage on Forrester Named ADP a Leader in HCM Wave 2025 Evaluation - ADP

Forrester Named ADP a Leader in HCM Wave 2025 Evaluation  ADP

Forrester Named ADP a Leader in HCM Wave 2025 Evaluation - ADP

Click here to get full coverage on Am I at Risk for Sudden Cardiac Death From Hypertrophic Cardiomyopathy (HCM)? - Everyday Health

Am I at Risk for Sudden Cardiac Death From Hypertrophic Cardiomyopathy (HCM)?  Everyday Health

Am I at Risk for Sudden Cardiac Death From Hypertrophic Cardiomyopathy (HCM)? - Everyday Health

Click here to get full coverage on Analysts Signal a Shift in HCM Software: 4 Ways Leaders Can Prepare - ADP

Analysts Signal a Shift in HCM Software: 4 Ways Leaders Can Prepare  ADP

Analysts Signal a Shift in HCM Software: 4 Ways Leaders Can Prepare - ADP

Click here to get full coverage on Mavacamten fails to boost outcomes for patients with nonobstructive HCM - Cardiovascular Business

Mavacamten fails to boost outcomes for patients with nonobstructive HCM  Cardiovascular Business

Mavacamten fails to boost outcomes for patients with nonobstructive HCM - Cardiovascular Business

Click here to get full coverage on Mavacamten’s Benefits Are Not Sex-Dependent and Include Sustained Cardiac Remodeling - Cleveland Clinic

Mavacamten’s Benefits Are Not Sex-Dependent and Include Sustained Cardiac Remodeling  Cleveland Clinic

Mavacamten’s Benefits Are Not Sex-Dependent and Include Sustained Cardiac Remodeling - Cleveland Clinic

Click here to get full coverage on FDA clears Cytokinetics' Myqorzo for obstructive HCM, will compete with BMS's Camzyos - FirstWord Pharma

FDA clears Cytokinetics' Myqorzo for obstructive HCM, will compete with BMS's Camzyos  FirstWord Pharma

FDA clears Cytokinetics' Myqorzo for obstructive HCM, will compete with BMS's Camzyos - FirstWord Pharma

Click here to get full coverage on Is Hypertrophic Cardiomyopathy Genetic? Here’s What You Need To Know - Cleveland Clinic Health Essentials

Is Hypertrophic Cardiomyopathy Genetic? Here’s What You Need To Know  Cleveland Clinic Health Essentials

HCM

Price Chart

Key Statistics

Technicals

About HCM

Latest News

The Skills Shortage is Here to Stay: Here’s What Organizations Need to Do Next - UC Today

7 Ways to Manage Obstructive Hypertrophic Cardiomyopathy Symptoms - Everyday Health

Edgewise Therapeutics Teases Phase 3 Sevasemten Readout, HCM Data Update at Guggenheim Conference - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers